Analysis of the therapeutic effect of rivaroxaban and dabigatran on left ventricular thrombus patients after acute myocardial infarction
CSTR:
Author:
Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
    Abstract:

    Objective:To explore on the therapeutic effect of rivaroxaban and dabigatran on left ventricular thrombus(LVT)patients after acute myocardial infarction(AMI).Methods:129 post AMI LVT patients who underwent emergency per-cutaneous coronary intervention(PCI)were divided into three groups according to different treatment methods:warfarin group(initial dose 2.5 mg,once a day,adjusted according to international standard ratio),rivaroxaban group(10 mg,once a day),and dabigatran group(110 mg,twice a day),with 43 patients in each group.The LVT dissolution rate,incidence rates of major ad-verse cardiovascular events(MACE),incidence rates of bleeding events,myocardial enzyme spectrum indexes[creatine kinase isoenzyme(CK-MB),lactate dehydrogenase(LDH),troponin Ⅰ(cTnⅠ)]and liver function indexes were compared among the three groups of patients within 3 months.Results:The dissolution rate of LVT in rivaroxaban group and dabigatran group was higher than that in warfarin group(P<0.05).The incidence rates of MACE were lower in rivaroxaban group and dabigatran group than those in warfarin group(P<0.05),but there were no statistical differences between rivaroxaban group and dabigat-ran group(P>0.05).The total incidence rate of bleeding events in rivaroxaban group and dabigatran group was lower com-pared with that in warfarin group(P<0.05).After 7 days and 1 month of treatment,the myocardial enzyme spectrum indexes such as CK-MB,LDH and cTnⅠ were lower in rivaroxaban group and dabigatran group compared to warfarin group(P<0.05),but no statistical differences were shown between rivaroxaban group and dabigatran group(P>0.05).The differences in liver function indexes such as ALT,AST and TB were not statistically significant among the three groups of patients at each time point before and after treatment(P>0.05).Conclusion:Rivaroxaban and dabigatran are equally effective in treating LVT pa-tients after AMI,and both are superior to warfarin.Both drugs can promote LVT dissolution,reduce the risk of MACE and bleeding events,promote myocardial function recovery,and have good treatment safety.

    Reference
    Related
    Cited by
Get Citation

刘雪瑜;林珍;欧阳山丹;杜江涛;徐昕;林利仙;.利伐沙班、达比加群对急性心肌梗死后左心室血栓患者的治疗效果分析[J]. Journal of North Sichuan Medical College,2025,40(10):1350-1353.

Copy
Related Videos

Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:
  • Revised:
  • Adopted:
  • Online: November 03,2025
  • Published:
Article QR Code